Allobarbital
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Allobarbital
- DrugBank Accession Number
- DB13577
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 208.217
Monoisotopic: 208.084792254 - Chemical Formula
- C10H12N2O3
- Synonyms
- Allobarbital
- Allobarbitalum
- External IDs
- NSC-9324
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your software1,2-Benzodiazepine The risk or severity of CNS depression can be increased when 1,2-Benzodiazepine is combined with Allobarbital. Acetazolamide The risk or severity of CNS depression can be increased when Acetazolamide is combined with Allobarbital. Acetophenazine The risk or severity of CNS depression can be increased when Acetophenazine is combined with Allobarbital. Agomelatine The risk or severity of CNS depression can be increased when Agomelatine is combined with Allobarbital. Alfentanil The risk or severity of CNS depression can be increased when Alfentanil is combined with Allobarbital. - Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image SPASMO-PANALGINE 125 MG 10 SUPOZITUAR Allobarbital (30 mg) + Acetaminophen (125 mg) + Adiphenine (25 mg) Suppository TÜRK EĞİTİM VAKFI 1963-01-21 Not applicable Turkey
Categories
- ATC Codes
- N05CA21 — Allobarbital
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as barbituric acid derivatives. These are compounds containing a perhydropyrimidine ring substituted at C-2, -4 and -6 by oxo groups.
- Kingdom
- Organic compounds
- Super Class
- Organoheterocyclic compounds
- Class
- Diazines
- Sub Class
- Pyrimidines and pyrimidine derivatives
- Direct Parent
- Barbituric acid derivatives
- Alternative Parents
- N-acyl ureas / Diazinanes / Dicarboximides / Azacyclic compounds / Organopnictogen compounds / Organonitrogen compounds / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds
- Substituents
- 1,3-diazinane / Aliphatic heteromonocyclic compound / Azacycle / Barbiturate / Carbonic acid derivative / Carbonyl group / Carboxylic acid derivative / Dicarboximide / Hydrocarbon derivative / N-acyl urea
- Molecular Framework
- Aliphatic heteromonocyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 8NT43GG2HA
- CAS number
- 52-43-7
- InChI Key
- FDQGNLOWMMVRQL-UHFFFAOYSA-N
- InChI
- InChI=1S/C10H12N2O3/c1-3-5-10(6-4-2)7(13)11-9(15)12-8(10)14/h3-4H,1-2,5-6H2,(H2,11,12,13,14,15)
- IUPAC Name
- 5,5-bis(prop-2-en-1-yl)-1,3-diazinane-2,4,6-trione
- SMILES
- C=CCC1(CC=C)C(=O)NC(=O)NC1=O
References
- General References
- Not Available
- External Links
- ChemSpider
- 5635
- 516
- ChEBI
- 134875
- ChEMBL
- CHEMBL267719
- ZINC
- ZINC000005193039
- Wikipedia
- Allobarbital
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Suppository - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 3.63 mg/mL ALOGPS logP 1.08 ALOGPS logP 1 Chemaxon logS -1.8 ALOGPS pKa (Strongest Acidic) 7.48 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 75.27 Å2 Chemaxon Rotatable Bond Count 4 Chemaxon Refractivity 53.54 m3·mol-1 Chemaxon Polarizability 19.92 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 151.2463719 predictedDarkChem Lite v0.1.0 [M-H]- 145.9538 predictedDeepCCS 1.0 (2019) [M+H]+ 151.8869719 predictedDarkChem Lite v0.1.0 [M+H]+ 148.34935 predictedDeepCCS 1.0 (2019) [M+Na]+ 154.73302 predictedDeepCCS 1.0 (2019)
Drug created at June 23, 2017 20:44 / Updated at February 21, 2021 18:54